Case Studies

“Capital + Talent = Huge Exit”

How the right CEO and Board Chair create the outcome needed.

NMS Capital had just acquired Clinical Trials of Texas, a founder-led clinical research organization with deep expertise but limited scale. The private equity playbook was clear: roll up CROs to build a national platform.

NMS needed a proven operator who could integrate acquisitions, standardize processes across multiple sites, and build the infrastructure for a strategic exit. They needed someone who had done this before. And they needed a Board Chair who could guide the transformation.

Canopy didn't just look for CRO insiders. We looked for executives who had taken fragmented regional businesses and turned them into integrated platforms.

Genstar Capital acquired that transformation in what industry insiders described as a "whopping exit." The platform the Canopy Candidates built was exactly what a larger PE firm was looking for.

“The Multiplier Effect”

One great hire can move the needle. A complete leadership team can change the trajectory of a company. That's the multiplier effect.

SciQuest had built a B2B SaaS platform for procurement and supply chain management. The product worked. Customers loved it. But the company had hit a ceiling.

They needed executives who had scaled B2B SaaS companies through rapid growth phases, could operate in a PE-backed environment, and had done this before and had the exits to prove it.

Over 18 months, we placed:

Chief Product Officer – to define the roadmap and drive differentiation
Chief Marketing Officer – to build a demand generation engine
Chief Technology Officer – to modernize the tech stack for scale
Chief People Officer – to build the culture and talent systems
VP of Sales – to professionalize the revenue organization

KKR took SciQuest private at a $509 million valuation. Why? Because the company had predictable revenue, a scalable platform, a deep product moat, and a world-class leadership team.

“$3 Billion Exit”

The right Chief People Officer doesn't manage HR, they architect the talent systems that create enterprise value.

BioAgilytix, a CRO specializing in bioanalytical testing for pharmaceutical companies, was experiencing explosive growth under GHO Capital ownership. The CEO knew that culture and talent would either fuel the next phase of growth or kill it. GHO was building toward a major exit, and they couldn't afford a talent crisis derailing valuation.

They needed a Chief People Officer who had scaled life sciences companies through rapid growth and positioned them for exits.

Within 18 months of Canopy filling this position:

Turnover dropped 25%
Employee engagement scores climbed into top quartile for life sciences
Leadership bench deepened with internal promotions
Culture became a competitive advantage in recruiting top scientific talent

Cinven acquired BioAgilytix for $3.2 billion. In the deal prospectus, buyers specifically cited the company's strong culture, employee retention, deep leadership bench, and scalable talent systems

Client Testimonials

"Over the last 10 years Christiaan has assisted me on over 50 placements. He has a network unlike anything I've seen. Especially in the world of private equity and meeting scalability demands, and the need for top talent. Almost all hires have high retention rates, as well. There is not a search I would not trust him with"

— Jodi Cheek, CPO Sigma7, Private Equity Partner, Board Member

"Over the last several years, I've gotten to know the Canopy Team professionally and personally and have relied on them in both areas for counsel and help. They have executed searches for me, advised me on Board placements, and within the community. Their networks and connectivity are second to none. I would never hesitate to use them as an executive search or board placement partner."

— Jim Datin, CEO, GHO Capital, Board Member